MedTrace Logo

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

NCT02965495 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-12-11

No results posted yet for this study

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YYD302 for treatment of osteoarthritis of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

YYD302 2ml

YYD302 2ml

DRUG

YYD302 3ml

YYD302 3ml

DRUG

Placebo 3ml

phosphate buffered saline 3ml

Sponsors & Collaborators

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chul-Won Ha, M.D · Samsung Medical Center, Department of Internal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02965495 on ClinicalTrials.gov